Evidence for an anti-parallel orientation of the ligand-activated human androgen receptor dimer.
about
DJ-1 positively regulates the androgen receptor by impairing the binding of PIASx alpha to the receptorIdentification and characterization of a novel androgen receptor coregulator ARA267-alpha in prostate cancer cellsRepressors of androgen and progesterone receptor actionA novel function of caspase-8 in the regulation of androgen-receptor-driven gene expressionStructure and function of steroid receptor AF1 transactivation domains: induction of active conformationsElectrostatic modulation in steroid receptor recruitment of LXXLL and FXXLF motifsGlucocorticoid receptor homodimers and glucocorticoid-mineralocorticoid receptor heterodimers form in the cytoplasm through alternative dimerization interfacesThe AF1 and AF2 domains of the androgen receptor interact with distinct regions of SRC1Multiple signal input and output domains of the 160-kilodalton nuclear receptor coactivator proteinsMelanoma antigen gene protein MAGE-11 regulates androgen receptor function by modulating the interdomain interactionOligospermic infertility associated with an androgen receptor mutation that disrupts interdomain and coactivator (TIF2) interactionsHuman checkpoint protein hRad9 functions as a negative coregulator to repress androgen receptor transactivation in prostate cancer cellsEpidermal-growth-factor-dependent phosphorylation and ubiquitinylation of MAGE-11 regulates its interaction with the androgen receptorThe cochaperone Bag-1L enhances androgen receptor action via interaction with the NH2-terminal region of the receptorLigand-specific dynamics of the androgen receptor at its response element in living cellsModulation of Androgen Receptor Activation Function 2 by Testosterone and DihydrotestosteroneLiganded androgen receptor interaction with beta-catenin: nuclear co-localization and modulation of transcriptional activity in neuronal cellsThe FXXLF motif mediates androgen receptor-specific interactions with coregulatorsCharacterization of niphatenones that inhibit androgen receptor N-terminal domainModulation of androgen receptor transactivation by the SWI3-related gene product (SRG3) in multiple waysAndrogen Receptor Exon 1 Mutation Causes Androgen Insensitivity by Creating Phosphorylation Site and Inhibiting Melanoma Antigen-A11 Activation of NH2- and Carboxyl-terminal Interaction-dependent TransactivationGain in Transcriptional Activity by Primate-specific Coevolution of Melanoma Antigen-A11 and Its Interaction Site in Androgen ReceptorAndrogen receptor phosphorylation: biological context and functional consequences.Inhibition of androgen receptor transcriptional activity as a novel mechanism of action of arsenic.20(S)-protopanaxadiol-aglycone downregulation of the full-length and splice variants of androgen receptor.Functional interaction of human Cdc37 with the androgen receptor but not with the glucocorticoid receptor.Beta-catenin binds to the activation function 2 region of the androgen receptor and modulates the effects of the N-terminal domain and TIF2 on ligand-dependent transcriptionHigh-throughput mammalian two-hybrid screening for protein-protein interactions using transfected cell arraysCR6-interacting factor 1 represses the transactivation of androgen receptor by direct interaction.Antiandrogen flutamide protects male mice from androgen-dependent toxicity in three models of spinal bulbar muscular atrophy.Androgen insensitivity.Analysis of exon 1 mutations in the androgen receptor gene.Mouse Zac1, a transcriptional coactivator and repressor for nuclear receptorsMechanistic relationship between androgen receptor polyglutamine tract truncation and androgen-dependent transcriptional hyperactivity in prostate cancer cells.An interdomain interaction of the androgen receptor is required for its aggregation and toxicity in spinal and bulbar muscular atrophy.Melanoma antigen-A11 (MAGE-A11) enhances transcriptional activity by linking androgen receptor dimers.The chicken ovalbumin upstream promoter-transcription factor II negatively regulates the transactivation of androgen receptor in prostate cancer cells.Feed-forward inhibition of androgen receptor activity by glucocorticoid action in human adipocytes.Transcriptional repression of the alpha-subunit gene by androgen receptor occurs independently of DNA binding but requires the DNA-binding and ligand-binding domains of the receptorMelanoma antigen gene protein-A11 (MAGE-11) F-box links the androgen receptor NH2-terminal transactivation domain to p160 coactivators.
P2860
Q24291490-AE3F06F9-5DA7-4DA5-8685-9D7CA5B78930Q24291571-6C0889E2-8394-4433-B87A-C5EFBCAD82A4Q24303288-3D1B3981-D07F-44D9-80BC-8077B5DF2D12Q24336995-13C04D9A-5EA9-46D8-950A-F5AAA74EB472Q24537137-0E4A0FB1-5233-4EE4-9025-544D78AB2160Q24550576-1442EC41-5C2D-4CBA-A2D5-88BA1E23754CQ24551024-5EF6F448-E5FF-4AF1-BC0E-985ED61AC76FQ24554379-749BFD0C-3374-40E5-849E-8BAEBEF5E7EBQ24554443-4294A4C3-AAED-4FF5-9116-159F8C5BF653Q24556963-C4442155-9581-41BF-A431-1DCEAE4BA60AQ24563222-8BA3DAAA-C891-464B-BE4C-9F424F4E4D90Q24607572-89A1C141-499B-438C-B7B1-3055D4B69671Q24652929-C5DCC098-29EB-4F45-BBA6-CA34F0CD7F67Q24652993-0F003FF4-073C-4069-B126-5F64FF7D0654Q24681534-A7562136-8D09-4F9A-B20D-D4476C3160A2Q27646416-12F4837B-B8E7-492C-B58B-6F677268C74CQ28210565-597635AD-0300-4EA4-AFCA-19A4F8D1D049Q28214781-0266DA95-A7B5-4191-9615-7D83720924ECQ28543404-46A56ACC-4BA6-467E-A994-D81E71878CA8Q28579299-91AEEAB3-2B47-472A-B797-D178891A7EAEQ29036974-A832550E-5F50-4FF2-93CB-5F34CD54DAC8Q29040033-E7149AAD-105B-4928-B9E8-1DFAC7C7D01FQ30394055-6949FA9D-2881-4561-A252-49A597666CC9Q30436959-2C7C4431-AB98-4A9B-A9A6-C7964D5E5419Q30528764-DA610B66-708E-4785-B2BE-E9AC58064C30Q31583023-C74264DF-7654-414E-BED2-E181FCA1C7E4Q33292178-467DFE7A-5CF9-4BDB-8387-699EAC65D858Q33318566-D8EBCCF7-0749-4C1E-8084-9FA17C3C122DQ33643292-D4A4C709-16CE-4AC8-B0C5-34B9893D4A5FQ33765455-0D4CD540-750A-4D06-BDEA-5D4579203D77Q33869547-B9725131-1C69-4B4D-8A30-F8D5D1F688BDQ33881302-2E6E1BB9-5312-401C-9A51-2D89015F46ECQ33962326-6809EE6D-93BB-491A-AEB9-4F664C8B552CQ33976024-60F47450-C413-48F0-AFF5-FFC173067DC7Q34285154-091DE90E-D9B4-4D72-8881-C195F9176CA0Q34313140-74967977-ED41-4A17-AF4E-2C3A7FC5E21FQ34473887-F51635E2-E4AB-4168-9660-86ECFB47C301Q34657242-63229E39-E0DC-4D78-BF64-0B0A5188DFE8Q34771755-262199AA-9DD2-40F9-B755-2302D7F96037Q35007914-3E924BEA-0DDC-4A57-A8F4-C33A1F08A080
P2860
Evidence for an anti-parallel orientation of the ligand-activated human androgen receptor dimer.
description
1995 nî lūn-bûn
@nan
1995 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Evidence for an anti-parallel ...... human androgen receptor dimer.
@ast
Evidence for an anti-parallel ...... human androgen receptor dimer.
@en
Evidence for an anti-parallel ...... human androgen receptor dimer.
@nl
type
label
Evidence for an anti-parallel ...... human androgen receptor dimer.
@ast
Evidence for an anti-parallel ...... human androgen receptor dimer.
@en
Evidence for an anti-parallel ...... human androgen receptor dimer.
@nl
prefLabel
Evidence for an anti-parallel ...... human androgen receptor dimer.
@ast
Evidence for an anti-parallel ...... human androgen receptor dimer.
@en
Evidence for an anti-parallel ...... human androgen receptor dimer.
@nl
P2093
P356
P1476
Evidence for an anti-parallel ...... human androgen receptor dimer.
@en
P2093
P304
29983-29990
P356
10.1074/JBC.270.50.29983
P407
P577
1995-12-01T00:00:00Z